Equities Research Analysts’ updated eps estimates for Monday, September 25th:

Roth Capital initiated coverage on shares of AIT Therapeutics (NASDAQ:AITB). They issued a buy rating and a $14.00 target price on the stock.

Ashmore Group (OTCMKTS:AJMPF) was downgraded by analysts at Numis Securities Ltd from a hold rating to a reduce rating.

Bayer AG (NASDAQ:BAYRY) was upgraded by analysts at BNP Paribas from a neutral rating to an outperform rating.

Banco Bilbao Vizcaya Argentaria (BME:BBVA) had its sell rating reaffirmed by analysts at Citigroup Inc..

Costco Wholesale Corporation (NASDAQ:COST) had its outperform rating reiterated by analysts at Robert W. Baird. The firm currently has a $200.00 target price on the stock.

Centrica PLC (NASDAQ:CPYYY) was upgraded by analysts at Investec from a sell rating to a hold rating.

Bryan, Garnier & Co initiated coverage on shares of Daimler AG (NASDAQ:DDAIF). Bryan, Garnier & Co issued a buy rating on the stock.

DISH Network Corporation (NASDAQ:DISH) had its buy rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $53.26 target price on the stock, down from their previous target price of $80.00.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Endo’s growth-by-acquisition strategy is impressive. Endo’s top line should continue to benefit from robust performance of Xiaflex and sterile injectables. Endo has centralized and streamlined its supply chain, quality and compliance organization in order to create a more cohesive and efficient structure. However, Endo’s generics base business and the legacy branded pain franchise are expected to decline further. The company’s Generic segment is under pressure given the challenging competitive landscape and pricing pressures. With the company pulling off Opana ER from the market over growing concern of opioid abuse epidemic, the top-line will be further impacted. Also, the Branded segment continues to be under pressure due to additional competitive entrants as well as a continuous rise in the number of public policy and regulatory actions. Shares of Endo have significantly underperformed the industry so far.”

General Mills (NYSE:GIS) had its neutral rating reissued by analysts at Credit Suisse Group. The firm currently has a $53.00 target price on the stock.

Alphabet (NASDAQ:GOOGL) had its buy rating reiterated by analysts at B. Riley. They currently have a $1,050.00 target price on the stock.

Alphabet (NASDAQ:GOOGL) had its buy rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $1,075.00 price target on the stock.

Inditex (NASDAQ:IDEXY) was downgraded by analysts at BNP Paribas from an outperform rating to a neutral rating.

Manchester United (NYSE:MANU) had its buy rating reiterated by analysts at Deutsche Bank AG. They currently have a $20.00 target price on the stock, up from their previous target price of $19.00.

MINDBODY (NASDAQ:MB) had its buy rating reiterated by analysts at Craig Hallum. Craig Hallum currently has a $30.00 price target on the stock.

Morgan Stanley (NYSE:MS) had its sell rating reaffirmed by analysts at Compass Point. Compass Point currently has a $38.00 target price on the stock, up from their previous target price of $34.00.

Susquehanna Bancshares Inc began coverage on shares of MSC Industrial Direct (NYSE:MSM). Susquehanna Bancshares Inc issued a neutral rating and a $77.00 price target on the stock.

Nike (NYSE:NKE) had its outperform rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $65.00 price target on the stock.

Nike (NYSE:NKE) had its hold rating reissued by analysts at Needham & Company LLC.

NVIDIA Corporation (NASDAQ:NVDA) had its buy rating reiterated by analysts at Mizuho.

Opko Health (NASDAQ:OPK) had its buy rating reaffirmed by analysts at Ladenburg Thalmann Financial Services. Ladenburg Thalmann Financial Services currently has a $16.00 price target on the stock.

Puretech Health PLC (LON:PRTC) had its buy rating reissued by analysts at N+1 Singer.

Rogers Communication (NYSE:RCI) (TSE:RCI.B) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $59.00 target price on the stock. According to Zacks, “Rogers Communications continues to remain the first wireless operator in Canada to offer Internet of Things as a service to business enterprises. The company’s wireless and cable segment has been doing well with huge wireless and high-speed internet subscriber gain. Rogers' Media arm inked two important deals – one with The Weather Company and an extended deal with Iowa-based media conglomerate company, Meredith Corporation. Over the past three months, the stock price grew 7.8% beating the industry's gain of 0.8%. The company has maintained its position as the largest integrated-telecom operator in Canada. On the other hand, the company operates in an intensely competitive wireless and cable TV industry. Also, continuous softness in the advertising market, declining cash flow and loss of viewers to video streaming service providers remain potent headwinds.”

River and Mercantile Group PLC (LON:RIV) had its buy rating reiterated by analysts at N+1 Singer. The firm currently has a GBX 400 ($5.39) target price on the stock.

Bryan, Garnier & Co assumed coverage on shares of RENAULT SA EUR3.81 (NASDAQ:RNSDF). They issued a buy rating on the stock.

Sanderson Farms (NASDAQ:SAFM) had its equal weight rating reissued by analysts at Stephens. Stephens currently has a $170.00 target price on the stock, up from their previous target price of $145.00.

Banco Santander, (BME:SAN) had its neutral rating reaffirmed by analysts at Citigroup Inc..

Capital One Financial Corporation started coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA). Capital One Financial Corporation issued an equal weight rating and a $24.00 target price on the stock.

Summit Financial Group (NASDAQ:SMMF) was downgraded by analysts at Sandler O’Neill from a buy rating to a hold rating.

Teck Resources (NYSE:TECK) (TSE:TECK) had its buy rating reissued by analysts at Deutsche Bank AG. The firm currently has a $26.00 target price on the stock, up from their previous target price of $24.00.

Trifast plc (LON:TRI) had its buy rating reiterated by analysts at N+1 Singer.

Texas Instruments (NASDAQ:TXN) had its buy rating reissued by analysts at Jefferies Group LLC. They currently have a $96.00 price target on the stock.

Vale (NYSE:VALE) had its equal weight rating reiterated by analysts at Morgan Stanley.

Versartis (NASDAQ:VSAR) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating.

Western Digital Corporation (NASDAQ:WDC) had its overweight rating reissued by analysts at Barclays PLC. Barclays PLC currently has a $131.00 target price on the stock.

Receive News & Ratings for AIT Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIT Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.